| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 03/29/2006 | EP1638551A2 Immunosuppressant compounds and compositions |
| 03/29/2006 | EP1034180B1 Linker nucleoside, and production and use of the same |
| 03/29/2006 | CN1753889A Quinazoline compounds |
| 03/29/2006 | CN1753882A Ethynyl derivatives serving as factor XA inhibitors |
| 03/29/2006 | CN1752093A Synthesis method of (R,S)-S-secondary butyl o-ethyl-2-oxo-1,3-thiazolidine-3-thiosulphate |
| 03/29/2006 | CN1752092A Synthesis method of 3-amino propylomine ethyl thio phosphoric acid |
| 03/29/2006 | CN1248514C Method and an arrangement for connecting and disconnecting communications links |
| 03/29/2006 | CN1247601C Method for preparing beta- phosphorus-contained nitroxide free radical |
| 03/29/2006 | CN1247600C Beta-trifluoromethylenolphosphate, synthesis method and application |
| 03/29/2006 | CN1247599C Transition metal salt of biological membrane phosphatidate and its synthesis method |
| 03/28/2006 | US7019173 Fluorine compound and fluorinating agent comprising the compound |
| 03/28/2006 | US7019139 Quinolinones and uses thereof |
| 03/28/2006 | US7019129 at least three radicals selected from substituted or unsubstituted aryl, heteroaryl and combinations, wherein at least two of the residues are covalently linked via an exocyclic diazo bond, and a reactive functional group providing a locus for conjugation of the quencher to a carrier |
| 03/28/2006 | US7019127 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester |
| 03/28/2006 | US7019056 Flame retardants which contain phosphorus, and flame-retardant thermoplastic molding compositions |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/28/2006 | US7018989 Chemical compounds |
| 03/28/2006 | US7018987 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018949 Substituted pyridyl amine catalysts and processes for polymerizing and polymers |
| 03/28/2006 | US7018797 Method for treating neurodegenerative disorders |
| 03/28/2006 | US7018559 Hydraulic fluids |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/23/2006 | WO2006031938A2 Oxidation catalyst and its use for catalyzing liquid phase oxidation reactions |
| 03/23/2006 | WO2006031180A1 Process for preparation of alkyl phosphinates |
| 03/23/2006 | WO2006029532A1 Nitrate esters and their use for mitigating cellular damage |
| 03/23/2006 | WO2005058917A3 New oxazoline ligands for asymmetric catalysis |
| 03/23/2006 | WO2005028434A3 Novel heterocyclic compounds as hsp90-inhibitors |
| 03/23/2006 | US20060063947 Benzofuranone stabilization of phosphate esters |
| 03/23/2006 | US20060063939 Process for manufacture of fosinopril sodium |
| 03/23/2006 | US20060063743 Peptide deformylase activated prodrugs |
| 03/23/2006 | US20060063706 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals; treating infection caused by methicillin-resistant Staphylococcus aureus |
| 03/23/2006 | US20060063220 Charcoal stabilization of phenyl phosphates |
| 03/23/2006 | US20060063155 Synthesizing the nanoparticles in a synthesis mixture and growing the nanoparticles during a synthesis period; adding a modifying reagent to the synthesis mixture; for coupling to biologically relevant molecules |
| 03/23/2006 | US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies |
| 03/23/2006 | US20060060837 Compound, a molecular switch employing the compound and a method of electronic switching |
| 03/23/2006 | DE102004036722A1 Verfahren zur Herstellung von Phosphonato-Silanen A process for preparing silanes phosphonato |
| 03/22/2006 | EP1637538A1 Crystalline carbapenem intermediate |
| 03/22/2006 | EP1637537A1 New medicaments |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1636586A2 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences |
| 03/22/2006 | EP1636243A2 Chiral ligands for application in asymmetric syntheses |
| 03/22/2006 | EP1636182A2 Prodrugs of mitotic kinesin inhibitors |
| 03/22/2006 | EP1636173A2 Ionic liquids containing guanidinium cations |
| 03/22/2006 | EP1636171A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator |
| 03/22/2006 | EP1635856A2 Saposin c-dops: a novel anti-tumor agent |
| 03/22/2006 | EP1635837A1 (3-((quinazolin-4-yl)amino)-1h-pyrazol-1-yl)acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer |
| 03/22/2006 | CN1751054A Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators |
| 03/22/2006 | CN1751053A Salts comprising cyanoborate anions |
| 03/22/2006 | CN1749261A Prosome compound water soluble salicylamide ammonium phosphate of CA4 and synthetic method |
| 03/22/2006 | CN1749249A Chiral ionic liquid and its preparing method |
| 03/22/2006 | CN1748706A Compositions of lecithin and flavonoid small molecule, preparing method and their use |
| 03/22/2006 | CN1246429C Phosphate fluorosurfactants for use in carbon dioxide |
| 03/21/2006 | US7015360 Reacting a prochiral or chiral olefinically unsaturated organic compound with carbon monoxide and hydrogen in the presence of an optically active metal-ligand complex catalyst to produce an optically active aldehyde product |
| 03/21/2006 | US7015351 Oxidation of N-(phosphonomethyl)iminodiacetic acid; crystallization |
| 03/21/2006 | US7015343 Ssequentially treating abietic acid calcium salt with acid, base and extracting with organic solvent to give abietic acid with less isomer; reacting abietic acid with Pd/C to provide dehydroabietic acid, then converting it to sulfodehydroabietic acid via sufonation, neutralizing with zinc or bismuth ion |
| 03/21/2006 | US7015341 Triacylglycerol oligomer products and methods of making same |
| 03/21/2006 | US7015243 Cyclohexyl prostaglandin analogs as EP4-receptor agonists |
| 03/21/2006 | CA2183250C Prodrugs of morpholine tachykinin receptor antagonists |
| 03/16/2006 | WO2006028970A1 Derivatives of thiazole and thiadiazole inhibitors of tyrosine phosphatases |
| 03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
| 03/16/2006 | WO2005115361A3 Androgen receptor modulators and method of treating disease using the same |
| 03/16/2006 | WO2005056499A3 Oligo(p-phenylene vinylene) amphiphiles and methods for self-assembly |
| 03/16/2006 | US20060058557 Assymetric ligands of P, As, or Sb, e.g., product of reacting the product of 3,3'-Di-t-butyl-1,1'-biphenyl phosphorochloridite and 3,3'-bis(trimethylsilyl)-5,5'-bis(2,4,6-trimethylphenyl)-2,2'-biphenol with hydroxy-3-methoxybenzyl alcohol; transition metal complexes used especially for hydroformylation |
| 03/16/2006 | US20060058542 Phosphine compound, its intermediate, its complex with palladium and a manufacturing method of unsaturated compounds by using the palladium complex |
| 03/16/2006 | US20060058523 Quinazoline compounds |
| 03/16/2006 | US20060058325 Therapeutic quniazoline derivatives |
| 03/16/2006 | US20060058304 Azaindole kinase inhibitors |
| 03/16/2006 | US20060058259 Human t-cell,lymphocyte virus; hepatitis virus |
| 03/16/2006 | US20060058178 Aromatic compounds containing nitrogen and p- functionalized amines, the production thereof and their use in catalytic reactions |
| 03/16/2006 | US20060057425 Combining epoxide with aqueous hydrobromic acid to form bromohydrin, isolating bromohydrin, removing water, combining bromohydrin with n-butyl lithium, wherein molar ratio of n-butyl lithium to bromohydrin is 2, adding chlorophosphine to above product and adding acid to product; efficiency in blue region |
| 03/16/2006 | US20060055088 Novel aromatic sulfonium salt compound, photo-acid generator comprising the same and photopolymerizable composition containing the same, resin composition for optical three-dimensional shaping and method of optically forming tree-dimensional shape |
| 03/16/2006 | DE102004038442A1 Verfahren zur Herstellung nicht klebender Phospholipid-Granulate A process for producing non-adhesive phospholipid granules |
| 03/16/2006 | DE102004035742A1 N-Phenylphosphorsäuretriamide, Verfahren zu ihrer Herstellung und deren Verwendung als Mittel zur Regulierung bzw. Hemmung der enzymatischen Harnstoff-Hydrolyse N-phenyl phosphoric acid, process for their preparation and their use as agents for regulation or inhibition of the enzymatic urea hydrolysis |
| 03/15/2006 | EP1635220A2 Oxime derivatives and the use thereof as photoinitiators |
| 03/15/2006 | EP1634886A2 Novel phosphorus-containing prodrug |
| 03/15/2006 | EP1634870A1 Process and intermediates for the selective synthesis of Fluvastatin |
| 03/15/2006 | EP1633762A1 Ligands |
| 03/15/2006 | EP1633477A1 Diphosphines, preparation and uses thereof |
| 03/15/2006 | EP1633362A2 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 03/15/2006 | EP1633336A2 Immunosuppressant compounds and compositions |
| 03/15/2006 | EP1485392B1 Bisphosphite ligands for carbonylation processes |
| 03/15/2006 | EP1294794B1 Method for preparing and using supported phosphazenium catalysts |
| 03/15/2006 | EP1227085B1 Process for producing optically active naphthalene derivative and optical resolver therefor |
| 03/15/2006 | EP1094821B1 Sulfur-containing phosphonoformate derivatives and their uses. |
| 03/15/2006 | CN1747957A Intermediate for 2-substituted carbapenem derivative and production process |
| 03/15/2006 | CN1746179A Optical purity 7,7'-twice substituted-2,2'-didiphenyl-phosphine-1,1'-dinaphthalene ligand and synthesis thereof |
| 03/15/2006 | CN1746161A 2-pyrimidine oxy-N-aryl 7-nitrile or organic phosphate benzylamine compound, its production and use thereof |
| 03/15/2006 | CN1745755A Nucleotide analog composition and synthesis method |
| 03/15/2006 | CN1245411C 3-methyl-2-amylene-4-alkyne-1-triphenyl phosphine halide and preparation method thereof |
| 03/15/2006 | CN1245410C 3-methyl-2-amylene-4-alkyne-1-phosphonate ester compound and preparation method thereof |
| 03/15/2006 | CN1245371C Process for the carbonylation of ethylene |
| 03/15/2006 | CN1245162C Synergistic precursor medicine compound for treating Alzheimer disease |
| 03/14/2006 | US7012162 ccomplexes with transition metal; hydrogenation catalyst |
| 03/14/2006 | US7011815 Magnetic resonance imaging; gadofosveset |
| 03/14/2006 | CA2294342C Process for synthesizing carbapenem side chain intermediates |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2214070C Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
| 03/14/2006 | CA2210631C Tricyclic benzazepine vasopressin antagonists |
| 03/09/2006 | WO2006026747A2 Diphenylethylene compounds and uses thereof |